Details for Patent: 9,125,868
✉ Email this page to a colleague
Which drugs does patent 9,125,868 protect, and when does it expire?
Patent 9,125,868 protects CONTRAVE and is included in one NDA.
This patent has eighteen patent family members in twelve countries.
Summary for Patent: 9,125,868
| Title: | Methods for administering weight loss medications |
| Abstract: | Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications. |
| Inventor(s): | McKinney; Anthony A. (San Diego, CA), Tollefson; Gary (Indianapolis, IN), Weber; Eckard (San Diego, CA), Soltero; Rick (Holly Springs, NC) |
| Assignee: | OREXIGEN THERAPEUTICS, INC. (La Jolla, CA) |
| Application Number: | 14/220,349 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,125,868 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; |
Drugs Protected by US Patent 9,125,868
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,125,868
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 063958 | ⤷ Sign Up | |||
| Australia | 2007319472 | ⤷ Sign Up | |||
| Canada | 2668885 | ⤷ Sign Up | |||
| Chile | 2007003246 | ⤷ Sign Up | |||
| China | 101573103 | ⤷ Sign Up | |||
| European Patent Office | 2088998 | ⤷ Sign Up | |||
| Japan | 2010508997 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
